Roger C. Lucas Ph.D.
Dr. Lucas is a Director of Techne Corporation, a Series A investor in ChemoCentryx. A founding member of the staff at R&D Systems, now a division of Techne, Dr. Lucas guided that company's marked growth over 10 years, where he was a principal architect of R&D Systems' innovative deal making and acquisition of key competitors.
Techne Corporation, through its two R&D Systems subsidiaries, is the world's largest manufacturer and supplier of immunoregulatory molecules to the biomedical research community.
Dr. Lucas also sits on the Board of St. Croix Medical, Discovery Genomics, Zelo Technologies, Printware and Visual Circuits.